Oppenheimer Asset Management Inc. Acquires 6,421 Shares of UnitedHealth Group Incorporated $UNH

Oppenheimer Asset Management Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 48,745 shares of the healthcare conglomerate’s stock after buying an additional 6,421 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in UnitedHealth Group were worth $16,832,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also bought and sold shares of the company. Norges Bank bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $3,837,207,000. Berkshire Hathaway Inc bought a new stake in UnitedHealth Group during the 2nd quarter valued at $1,572,193,000. Dodge & Cox lifted its stake in shares of UnitedHealth Group by 117.7% in the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock valued at $2,729,912,000 after buying an additional 4,730,192 shares in the last quarter. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth about $528,273,000. Finally, Amundi lifted its position in UnitedHealth Group by 33.8% in the 2nd quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate’s stock valued at $1,904,372,000 after acquiring an additional 1,565,245 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $275.17 on Tuesday. The firm has a market cap of $249.26 billion, a price-to-earnings ratio of 20.86, a price-to-earnings-growth ratio of 1.27 and a beta of 0.41. The stock has a fifty day simple moving average of $324.91 and a two-hundred day simple moving average of $323.43. The company has a current ratio of 0.79, a quick ratio of 0.82 and a debt-to-equity ratio of 0.72. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. The company had revenue of $113.22 billion during the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently commented on UNH. TD Cowen increased their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. The Goldman Sachs Group started coverage on UnitedHealth Group in a research note on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective on the stock. Leerink Partners lowered their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research report on Friday, January 23rd. Finally, Barclays dropped their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.